Teleflex (TFX) to Release Earnings on Thursday

Teleflex (NYSE:TFX) will post its quarterly earnings results before the market opens on Thursday, May 2nd. Analysts expect Teleflex to post earnings of $3.07 per share for the quarter. Teleflex has set its FY 2024 guidance at 13.550-13.950 EPS and its FY24 guidance at $13.55-$13.95 EPS.Individual that are interested in registering for the company’s earnings conference call can do so using this link.

Teleflex (NYSE:TFX) last announced its quarterly earnings data on Thursday, February 22nd. The medical technology company reported $3.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.26 by $0.12. Teleflex had a net margin of 11.98% and a return on equity of 14.98%. The company had revenue of $773.90 million during the quarter, compared to analysts’ expectations of $769.01 million. During the same quarter in the prior year, the company earned $3.52 EPS. Teleflex’s revenue was up 2.1% compared to the same quarter last year. On average, analysts expect Teleflex to post $14 EPS for the current fiscal year and $15 EPS for the next fiscal year.

Teleflex Stock Up 0.0 %

Shares of NYSE TFX opened at $211.17 on Thursday. Teleflex has a 12-month low of $177.63 and a 12-month high of $276.43. The stock has a market cap of $9.95 billion, a PE ratio of 28.04, a P/E/G ratio of 1.98 and a beta of 1.11. The company has a current ratio of 2.32, a quick ratio of 1.29 and a debt-to-equity ratio of 0.39. The company has a 50-day moving average of $223.09 and a 200 day moving average of $225.66.

Teleflex Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 15th. Investors of record on Friday, March 1st were paid a dividend of $0.34 per share. The ex-dividend date of this dividend was Thursday, February 29th. This represents a $1.36 annualized dividend and a yield of 0.64%. Teleflex’s dividend payout ratio is presently 18.06%.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on TFX. Royal Bank of Canada dropped their price target on shares of Teleflex from $272.00 to $265.00 and set an “outperform” rating for the company in a research note on Friday, February 23rd. StockNews.com cut shares of Teleflex from a “buy” rating to a “hold” rating in a research note on Friday, February 23rd. JMP Securities reissued a “market outperform” rating and issued a $285.00 price target on shares of Teleflex in a research note on Friday, February 23rd. Finally, Truist Financial dropped their price target on shares of Teleflex from $270.00 to $265.00 and set a “hold” rating for the company in a research note on Friday, February 23rd. Five research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $267.50.

Insiders Place Their Bets

In other Teleflex news, VP Cameron P. Hicks sold 7,401 shares of the stock in a transaction that occurred on Tuesday, March 5th. The shares were sold at an average price of $225.00, for a total transaction of $1,665,225.00. Following the sale, the vice president now directly owns 10,050 shares in the company, valued at approximately $2,261,250. The transaction was disclosed in a document filed with the SEC, which is available through this link. 1.43% of the stock is owned by company insiders.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.